A
Asterias Biotherapeutics
Asterias Biotherapeutics, Inc, a development stage biotechnology company
About Asterias Biotherapeutics
Asterias Biotherapeutics is a biotechnology company focused on developing innovative cell-based therapies to address unmet medical needs in neurology and oncology. The company operates in the biopharmaceutical market, primarily serving patients with severe medical conditions such as spinal cord injuries and cancer. Asterias Biotherapeutics employs a business model centered around research and development (R&D) of proprietary stem cell technologies, which are then advanced through clinical trials. Revenue is generated through a combination of licensing agreements, partnerships with larger pharmaceutical companies, and potential future product sales. The company leverages its expertise in regenerative medicine to create therapies that can potentially restore function and improve the quality of life for patients. Key products in their pipeline include AST-OPC1 for spinal cord injuries and VAC2 for cancer immunotherapy. Asterias Biotherapeutics aims to bring these groundbreaking treatments to market, thereby addressing critical gaps in current medical care.
Source: Dealroom company dataNews
Open roles
Asterias Biotherapeutics in the Fremont ecosystem
The Asterias Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- PLPedro Lichtinger
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Asterias Biotherapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Asterias Biotherapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
